Adults with inflammatory bowel disease (IBD) who have a high visceral adipose tissue (VAT) burden may need a higher dose of infliximab to achieve clinical and endoscopic remission. In a prospective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback